The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model

por Cleanthous, Sophie, Strzok, Sara, Haier, Birgit, Cano, Stefan, Morel, Thomas
Publicado 2021

Correction to: The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model

por Cleanthous, Sophie, Strzok, Sara, Haier, Birgit, Cano, Stefan, Morel, Thomas
Publicado 2021

First‐in‐human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL‐17A and IL‐17F, in mild psoriasis

por Glatt, Sophie, Helmer, Eric, Haier, Birgit, Strimenopoulou, Foteini, Price, Graham, Vajjah, Pavan, Harari, Olivier A., Lambert, John, Shaw, Stevan
Publicado 2017

The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus

por Morel, Thomas, Cano, Stefan, Bartlett, Susan J, Gordon, Caroline, Haier, Birgit, Regnault, Antoine, Schneider, Matthias, Stach, Christian, Cleanthous, Sophie
Publicado 2021

Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

por Furie, Richard A, Bruce, Ian N, Dörner, Thomas, Leon, Manuel Gustavo, Leszczyński, Piotr, Urowitz, Murray, Haier, Birgit, Jimenez, Teri, Brittain, Claire, Liu, Jiajun, Barbey, Catherine, Stach, Christian
Publicado 2021